Rajendran C. Gopalan

Rajendran C. Gopalan

Auto-generated profile, based on publicly available information

Rajendran C. Gopalan

School of Pharmacy and Medical Sciences, University of Bradford, Bradford, UK

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2020 in Expert Review of Anti-infective Therapy
Verified
Journal Article
Closed access
KHKhaled Habas
Khaled Habas
CNChioma Nganwuchu
Chioma Nganwuchu
FSFanila Shahzad
Fanila Shahzad
RGRajendran Gopalan
Rajendran Gopalan
MHMainul Haque
Mainul Haque
Md Talat NasimMd Talat Nasim
Md Talat Nasim
Coronavirus disease 2019 (COVID-19) was first detected in China in December, 2019, and declared as a pandemic by the World Health Organization (WHO) on March 11, 2020. The current management of COV...

1 January 2009 in Nanotoxicology
Verified
Journal Article
Closed access
RGRajendran C. Gopalan
Rajendran C. Gopalan
IOIlham F. Osman
Ilham F. Osman
AAAmir Amani
Amir Amani
MMMarcel De Matas
Marcel De Matas
DADiana Anderson
Diana Anderson
The present study has examined the effects of ZnO and TiO2 nanoparticles (40–70 nm range) in the presence and absence of UVA light in human sperm and human lymphocytes in the dark (D), after pre-irradiation with UV (PI) and simultaneous irradiation with UV (SI). For both ZnO and TiO2 nanoparticles, the percentage reduction in head DNA was greater for PI and SI samples compared with samples treated in the dark. However with regard to photogenotoxicity, sperm exhibited no significant differences when the results for PI and SI and the dark were compared, except at the lowest concentration for SI samples in the case of ZnO and the lowest concentration for PI in the case of TiO2. However for lymphocytes, responses were statistically significant at the highest concentration for both PI and SI samples. Thus, these studies suggest that there are photogenotoxic events in these cells in the absence of overt toxicity.

1 February 2019 in International Journal of Pharmaceutics
Verified
Journal Article
Open access
YAYuosef. Al Ayoub
Yuosef. Al Ayoub
RGR.C. Gopalan
R.C. Gopalan
MNM. Najafzadeh
M. Najafzadeh
MMM.A. Mohammad
M.A. Mohammad
DAD. Anderson
D. Anderson
KAKhaled Assi
Khaled Assi
Extensive research has demonstrated the potential effectiveness of curcumin against various diseases, including asthma and cancers. However, few studies have used liquid-based vehicles in the preparation of curcumin formulations. Therefore, the current study proposed the use of nanoemulsion and microsuspension formulations to prepare nebulised curcuminoid for lung delivery. Furthermore, this work expressed a new approach to understanding the aerosol performance of nanoparticles compared to microsuspension formulations. The genotoxicity of the formulations was also assessed. Curcuminoid nanoemulsion formulations were prepared in three concentrations (100, 250 and 500 µg/ml) using limonene and oleic acid as oil phases, while microsuspension solutions were prepared by suspending curcuminoid particles in isotonic solution (saline solution) of 0.02% Tween 80. The average fine particle fraction (FPF) and mass median aerodynamic diameter (MMAD) of the nebulised microsuspension formulations ranged from 26% and 7.1 µm to 40% and 5.7 µm, for 1000 µg/ml and 100 µg/ml respectively. In a comparison of the low and high drug concentrations of the nebulised nanoemulsion, the average FPF and MMAD of the nebulised nanoemulsion formulations prepared with limonene oil ranged from 50% and 4.6 µm to 45% and 5.6 µm, respectively; whereas the FPF and MMAD of the nebulised nanoemulsion prepared with oleic acid oil ranged from 46% and 4.9 µm to 44% and 5.6 µm, respectively. The aerosol performance of the microsuspension formulations were concentration dependent, while the nanoemulsion formulations did not appear to be dependent on the curcuminoids concentration. The performance and genotoxicity results of the formulations suggest the suitability of these preparations for further inhalation studies in animals.

1 December 2014 in Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
Verified
Journal Article
Closed access
AAAftab Ali
Aftab Ali
MKMalgorzata Kurzawa-Zegota
Malgorzata Kurzawa-Zegota
MNMojgan Najafzadeh
Mojgan Najafzadeh
RGRajendran C. Gopalan
Rajendran C. Gopalan
MPMichael J. Plewa
Michael J. Plewa
DADiana Anderson
Diana Anderson

1 December 2011 in Toxicology Letters
Verified
Journal Article
Closed access
RGRajendran C. Gopalan
Rajendran C. Gopalan
EEEsra Emerce
Esra Emerce
CWColin W. Wright
Colin W. Wright
BKBensu Karahalil
Bensu Karahalil
AKAli E. Karakaya
Ali E. Karakaya
DADiana Anderson
Diana Anderson

25 July 2014 in The FASEB Journal
Verified
Journal Article
Closed access
DADiana Anderson
Diana Anderson
MNMojgan Najafzadeh
Mojgan Najafzadeh
RGRajendran Gopalan
Rajendran Gopalan
NGNader Ghaderi
Nader Ghaderi
ASAndrew J. Scally
Andrew J. Scally
MDMorgan C. Denyer
Morgan C. Denyer